5.2.6 Peroxisome proliferator activated receptor (PPAR) signaling pathway BBR ameliorates IR in HepG2 cells by modulating PPAR signaling pathway in KEGG enrichment analysis and free fatty acid-induced insulin resistant HepG2 cell model (IR-HepG2) ( 5.3 BBR ameliorates DM by modulating disturbances in glucose and lipid metabolism Metabolic disorders (e.g., dyslipidemia) are closely related to DM, and studies have shown that BBR has a significant regulatory effect on metabolic disorders, including affecting the function of pancreatic -cells, regulating the levels of cholesterol and triglycerides in the blood, and promoting fecal lipid excretion (Nazari et al., 2024
Tirzepatide activates two pathways rather than one, sometimes producing different gastrointestinal responses in patients whose baseline digestion is already altered
Symptoms include chronic headaches, pulsatile tinnitus
Gaps in GLP-1 treatment can cause withdrawal effects including appetite rebound, weight regain, and metabolic disruption
Users should consult a healthcare professional before starting semaglutide and discuss potential drug interactions or allergies they might have so that the best decisions are made when it comes to their health
